Delivery Order SPE2DR25D9331-SPE2DR26FQQB6
- Not listed
- The Defense Logistics Agency awarded a $15,108.96 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vial format. The delivery order, issued on January 14, 2026, with an ultimate completion date of February 5, 2026, carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This award...
- The Defense Logistics Agency awarded a $22,270.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vial format. This delivery order, issued on December 11, 2025, with an ultimate completion date of January 5, 2026, carries no set-aside designation, indicating the company competed successfully in an unrestricted procurement environment....
- The Defense Logistics Agency awarded a $5,036.32 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (Yellow Fever vaccine) in one-dose vial format. The contract, issued on January 13, 2026, with an ultimate completion date of February 4, 2026, carries no set-aside designation, indicating the award was made through full and open competition. This delivery order is issued under DMS...
- The Defense Logistics Agency issued a delivery order valued at $62,954.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vials. This firm fixed-price delivery order, awarded on January 9, 2026, with an ultimate completion date of February 2, 2026, was issued without a set-aside designation, reflecting the contractor's competitive capabilities in unrestricted...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,135.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. The contract, issued on December 16, 2025, with an ultimate completion date of January 8, 2026, contains no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,147.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vial format. The contract, issued on December 22, 2025, with an ultimate completion date of January 14, 2026, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency issued a delivery order valued at $2,227.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1-dose vials. This firm fixed-price delivery order, awarded on November 26, 2025, with an ultimate completion date of December 18, 2025, contains no set-aside designation, indicating the award was made through unrestricted federal procurement. The order was issued under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a $8,268.15 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) one-dose vials. The delivery order was issued on January 14, 2026, with an ultimate completion date of February 5, 2026, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (SPE2DR) with...
- The Defense Logistics Agency awarded a $11,135.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The contract, issued on December 11, 2025, with an ultimate completion date of January 5, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order falls under DMS...
- The Defense Logistics Agency awarded a $27,835.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted...
- SPE2DR25D9331Indefinite Delivery Contract
- SPE2DR25D9331-SPE2DR26FQQB6Delivery Order
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $50,363.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1 dose vials. The delivery order, awarded on January 14, 2026, with an ultimate completion date of February 5, 2026, carries no set-aside designation, indicating the contractor competed in unrestricted federal procurement. This award was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a comprehensive product portfolio encompassing branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals. The company's performance under the PPV-G GEN V contract, which carries a ceiling value of $499,999,999 and extends through December 31, 2036, demonstrates its capability to fulfill the diverse pharmaceutical requirements of military healthcare operations globally. YF-VAX, a yellow fever vaccine, represents one of the routine immunological products the contractor supplies to support Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.4k | 1/13/26 |